blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2670424

EP2670424 - CARDIOTROPHIN RELATED MOLECULES FOR ENHANCED THERAPEUTICS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  04.11.2015
Database last updated on 11.05.2024
Most recent event   Tooltip04.11.2015Withdrawal of applicationpublished on 02.12.2015  [2015/49]
Applicant(s)For all designated states
Fate Therapeutics, Inc.
Suite 200, 3535 General Atomics Court
San Diego, California 92121 / US
[2013/50]
Inventor(s)01 / LEE, Tom Tong
9308 Galvin Avenue
San Diego, California 92126 / US
02 / LAI, Kevin
8233 Station Village Lane
Unit 2305
San Diego, CA 92108 / US
03 / MENDLEIN, John
1550 Neptune Ave.
Encinitas, CA 92024 / US
04 / FLYNN, Peter
611 Sea Lane
La Jolla, CA 92037 / US
 [2013/50]
Representative(s)Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Ganghoferstraße 68 B
80339 München / DE
[N/P]
Former [2013/50]Schiweck, Weinzierl & Koch
European Patent Attorneys Landsberger Straße 98
80339 München / DE
Application number, filing date12741723.601.02.2012
WO2012US23534
Priority number, dateUS201161438581P01.02.2011         Original published format: US 201161438581 P
US201161438607P01.02.2011         Original published format: US 201161438607 P
US201161439803P04.02.2011         Original published format: US 201161439803 P
US201161439801P04.02.2011         Original published format: US 201161439801 P
[2013/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012106463
Date:09.08.2012
Language:EN
[2012/32]
Type: A2 Application without search report 
No.:EP2670424
Date:11.12.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 09.08.2012 takes the place of the publication of the European patent application.
[2013/50]
Search report(s)International search report - published on:KR20.12.2012
(Supplementary) European search report - dispatched on:EP01.12.2014
ClassificationIPC:A61K38/17, A61K38/16, C07K14/47, A61P29/00, A61K38/00, C07K14/52
[2015/01]
CPC:
C07K14/52 (EP,US); A61P1/16 (EP); A61P29/00 (EP);
A61P9/00 (EP); A61P9/10 (EP); A61P9/12 (EP);
A61K38/00 (EP,US) (-)
Former IPC [2013/50]A61K38/17, A61K38/16, C07K14/47, A61P29/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/50]
TitleGerman:CARDIOTROPHIN-VERWANDTE MOLEKÜLE FÜR VERBESSERTE THERAPEUTIKA[2013/50]
English:CARDIOTROPHIN RELATED MOLECULES FOR ENHANCED THERAPEUTICS[2013/50]
French:MOLÉCULES LIÉES À LA CARDIOTROPHINE POUR THÉRAPEUTIQUE AMÉLIORÉE[2013/50]
Entry into regional phase30.08.2013National basic fee paid 
30.08.2013Search fee paid 
30.08.2013Designation fee(s) paid 
30.08.2013Examination fee paid 
Examination procedure30.08.2013Examination requested  [2013/50]
29.06.2015Amendment by applicant (claims and/or description)
26.10.2015Application withdrawn by applicant  [2015/49]
Fees paidRenewal fee
27.02.2014Renewal fee patent year 03
26.02.2015Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2009042795  (FERNANDO PASAN [CA], et al) [A] 1-15* claim 8 *
International search[A]US5624806  (BAKER JOFFRE [US], et al);
 [A]US2004018586  (ROSENDAHL MARY S [US], et al);
 [A]US7253267  (COX III GEORGE N [US]);
 [X]  - PROTEIN, (20100601), Database accession no. XP_001103315, XP055120816
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.